Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Obsidio™ Conformable Embolic Registry

NCT: NCT06170619 · COMPLETED

NCT IDNCT06170619
StatusCOMPLETED
Start Date2024-06-19
Completion2025-09-09
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑